Biotechblog – Page 1051 – Biotechnology business, policy, and more!

Manufacturing is dead. Long live manufacturing!

On the same day that AstraZeneca has announced that it intents to completely outsource all of its drug manufacturing, citing […]

I’ll be attending the Mid-Atlantic Bio in Bethesda in late October. On November 8th I’ll be in Turkey speaking at

With the start of a new school year, a new cohort of students are entering biotechnology programs. In order to

Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal

Amgen’s got a record of savvy patenting to protect their blockbusters, and they’ve just done it again. A U.S. Federal

The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last

The FDA approved 38 drugs through July this year, down 31 percent from 55 approvals for the same period last

Welcome to the second August 2007 edition of Carnival of Biotechnology. International Biotechnology The Times (UK) has a report on

I’ve recently joined the Journal of Commercial Biotechnology as managing editor. Drop me a line if you would like to

I’m in the final stages of preparing a book on best practices in biotechnology business development, and am looking for